Europe In-Vitro Diagnostics Market Was Valued at US$ 24.85 Billion in 2023 and is Projected to Attain a Market Size of US$ 36.93 Billion by 2032 at a CAGR of 4.5% During the Forecast Period 2024-2032 | Astute Analytica

The 𝐄𝐮𝐫𝐨𝐩𝐞 𝐢𝐧-𝐯𝐢𝐭𝐫𝐨 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 (𝐈𝐕𝐃) 𝐦𝐚𝐫𝐤𝐞𝐭 was valued at 𝐔𝐒$ 𝟐𝟒.𝟖𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 and is projected to grow significantly, reaching a market size of 𝐔𝐒$ 𝟑𝟔.𝟗𝟑 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐. This growth represents a robust Compound Annual Growth Rate (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟒.𝟓% during the forecast period from 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟐.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 @: https://www.astuteanalytica.com/request-sample/europe-in-vitro-diagnostics-market

The in-vitro diagnostics market in Europe has seen substantial growth due to advancements in medical technology, increasing prevalence of chronic diseases, and a growing focus on preventive healthcare. The rising demand for accurate and timely diagnostic solutions has driven innovation and development in the IVD sector, contributing to its expansion.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬

𝐃𝐫𝐢𝐯𝐞𝐫: 𝐓𝐡𝐞 𝐀𝐠𝐢𝐧𝐠 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐃𝐞𝐦𝐨𝐠𝐫𝐚𝐩𝐡𝐲 𝐚𝐧𝐝 𝐂𝐡𝐫𝐨𝐧𝐢𝐜 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐁𝐮𝐫𝐝𝐞𝐧

Europe is home to one of the oldest populations globally. According to the World Health Organization, by 2050, approximately 40% of Europeans will be over 60 years old. This aging population is accompanied by an increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancers. The European Heart Network estimates that cardiovascular diseases alone account for over 3.9 million deaths annually in Europe, which is around 45% of all deaths.

Such health challenges necessitate early diagnosis, monitoring, and management, making IVD tools indispensable. IVD devices and services, which offer timely and accurate detection, are now more critical than ever. These diagnostics enable better patient management, guide treatment plans, and significantly reduce the associated healthcare costs. Thus, the growing geriatric populace coupled with the escalating chronic disease burden acts as a powerful driver for the In-vitro diagnostics market in Europe.

𝐓𝐨𝐩 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞 𝐈𝐧-𝐕𝐢𝐭𝐫𝐨 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

• Abbott
• Agilent Technologies, Inc.
• Becton Dickinson and Company
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Charles River Laboratories
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Qiagen
• Quest Diagnostics
• Quidel Corp.
• Siemens Healthineers
• Sysmex Corp.
• Other Prominent Players

𝐑𝐞𝐚𝐝 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐈𝐧𝐝𝐞𝐱 𝐨𝐟 𝐟𝐮𝐥𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐭𝐮𝐝𝐲 𝐚𝐭 @ https://www.astuteanalytica.com/request-sample/europe-in-vitro-diagnostics-market

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 & 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬

• Reagents
• Instruments
• Software
• Services

𝐁𝐲 𝐓𝐞𝐜𝐡𝐧𝐢𝐪𝐮𝐞

• Immunodiagnostics
• Hematology
• Molecular Diagnostics
• Tissue Diagnostics
• Clinical Chemistry
• Others

𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

• Cancer diagnostics
• Blood glucose monitoring
• Human genetic testing
• Immunoassays
• Hepatitis tests
• Infectious Diseases diagnostics
• Cardiac Diseases
• Nephrological Diseases
• Gastrointestinal Diseases
• Others

𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫

• Standalone Laboratories
• Hospitals
• Academic And Medical Schools
• Point Of Care
• Others

𝐁𝐲 𝐄𝐮𝐫𝐨𝐩𝐞

• Western Europe
o The UK
o Germany
o France
o Italy
o Spain
o Rest of Western Europe

• 𝐄𝐚𝐬𝐭𝐞𝐫𝐧 𝐄𝐮𝐫𝐨𝐩𝐞

o Poland
o Russia
o Rest of Eastern Europe

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 @ https://www.astuteanalytica.com/request-sample/europe-in-vitro-diagnostics-market

𝐀𝐛𝐨𝐮𝐭 𝐀𝐬𝐭𝐮𝐭𝐞 𝐀𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐚:

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyse for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

𝐆𝐞𝐭 𝐢𝐧 𝐭𝐨𝐮𝐜𝐡 𝐰𝐢𝐭𝐡 𝐮𝐬
𝐏𝐡𝐨𝐧𝐞 𝐧𝐮𝐦𝐛𝐞𝐫:+18884296757
𝐄𝐦𝐚𝐢𝐥: sales@astuteanalytica.com
𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://www.astuteanalytica.com/
LinkedIn | Twitter | YouTube | Facebook

This release was published on openPR.